Douala hospital adopts artificial intelligence to trigger healthcare leapfrogging mov't - Journal du Cameroun

The Bonassama District Hospital in Douala, Cameroon and six other African hospitals are adopting SOPHiA to – no matter their experience in genomic testing – get up to speed and analyze genomic data to identify disease-causing mutations in patients' genomic profiles, and decide on the most effective care. A release from the global leader in Data-Driven Medicine, Sophia Genetics, says in addition to the Bonassama district hospital, the modern technology is being adopted by Pharma Process in Casablanca, Morocco; ImmCell in Rabat, Morocco; The Al Azhar Oncology Center in Rabat, Morocco; The Riad Biology Center in Rabat, Morocco; The Oudayas, Medical Analysis Laboratory, Morocco;and The Center for Proteomic & Genomic Research (CPGR) in Cape Town, South Africa. As new users of SOPHiA, they become part of a larger network of 260 hospitals in 46 countries that share clinical insights across patient cases and patient populations, which feeds a knowledgebase of biomedical findings to accelerate diagnostics and care. Speaking about the adoption of SOPHiA in Africa, Jurgi Camblong, Sophia Genetics' CEO and co-founder, declared: "Since inception, our vision has been to develop innovative technological solutions that analyze patients' genomic profiles to offer better diagnosis and care to the greatest number of patients, wherever they live. Today, I am very proud that SOPHiA is triggering a technological leapfrog movement in healthcare across Africa."